ICLR ICON plc Forecast, Technical & Fundamental Analysis
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms... Show more
ICLR is expected to report earnings to rise 4.69% to $2.68 per share on October 28
Q3'26
Est.
$2.68
Q2'26
Beat
by $0.01
Q1'26
Missed
by $0.48
Q4'25
Missed
by $0.11
Q3'25
Beat
by $0.01
The last earnings report on July 29 showed earnings per share of $2.56, beating the estimate of $2.55. With 274.24K shares outstanding, the current market capitalization sits at 12.64B.
A.I. Advisor
published General Information
General Information
a provider of clinical research and development services
A.I.dvisor indicates that over the last year, ICLR has been loosely correlated with RGEN. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ICLR jumps, then RGEN could also see price increases.
ICLR in upward trend: price may ascend as a result of having broken its lower Bollinger Band on September 01, 2026
ICLR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 39 cases where ICLR's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ICLR advanced for three days, in of 311 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 213 cases where ICLR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on August 31, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ICLR as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for ICLR turned negative on August 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .
ICLR moved below its 50-day moving average on August 31, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ICLR crossed bearishly below the 50-day moving average on September 03, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICLR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ICLR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.348) is normal, around the industry mean (60.294). P/E Ratio (251.977) is within average values for comparable stocks, (157.369). ICLR's Projected Growth (PEG Ratio) (0.498) is slightly lower than the industry average of (1.552). ICLR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.007). P/S Ratio (1.530) is also within normal values, averaging (10.350).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICLR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
